OP Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
CWP
OP Asset Management's PFE Position: Q2 2026 in Review
OP Asset Management reduced its Pfizer (PFE) stake by 37% in Q2 2026, selling an estimated $9.64M and leaving 633,811 shares worth $15.3M. The position accounts for 0.16% of the portfolio, ranked #100.
OP Asset Management first reported a position in PFE in Q1 2025 and has held it in 6 quarters since. The position peaked at $28.2M in Q1 2026. 1,247 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- OP Asset Management held 633,811 shares of Pfizer worth $15.3M as of Q2 2026.
- OP Asset Management sold 368,694 Pfizer shares in Q2 2026, an estimated $9.64M.
- Pfizer made up 0.16% of OP Asset Management's portfolio in Q2 2026, its #100 holding.
- OP Asset Management first reported a position in Pfizer in Q1 2025 and has held it in 6 quarters since.
- OP Asset Management's Pfizer position peaked at $28.2M in Q1 2026.
- 1,247 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.